Summary of Expertise, Experience and Affiliations and Interests for the Scientific Advisory Committee on Medical Devices Used in Cardiovascular Systems (SAC-MDUCS)

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Contact: Policy Bureau Enquiries

Related Information: Scientific Advisory Committee on Medical Devices used in Cardiovascular System - Membership List and Biographies

Purpose of Summary

The following summarizes the information about expertise or experience, affiliations and interests relevant to the Scientific Advisory Committee on Medical Devices Used in the Cardiovascular System (SAC-MDUCS) mandate declared by committee members. Health Canada considered these declarations as part of the selection process. The Health Products and Food Branch has made this summary available as part of its commitment to be transparent about the membership of its advisory bodies.

Assessment of affiliations and interests prior to each meeting

Prior to each committee meeting, Health Canada assesses members' affiliations and interests, including direct financial interests, as they may apply to agenda items for discussion. Depending on the nature of the member's affiliations or interests, the Chair of the committee in consultation with the members, may limit the participation of a member in the meeting or ask him/her to make a verbal statement of affiliations and interests at the beginning of the meeting. Members' affiliations and interests are reviewed on an annual basis and updated as required based on changes in the status of their affiliations and interests.

In accordance with the Health Products and Food Branch Review of Regulated Products: Policy on Public Input and Guidance on Advisory Bodies, a person with a direct financial interest in the outcome of a review of a regulated product may be a member of an advisory body whose broader mandate encompasses matters of policy, management, or program development. However, such a member would not be asked to participate in any discussion, formulation of advice, or recommendations to Health Canada relating to that review.

Indicated [Sector/Perspective] and [Expertise/Experience]

Sector/perspective:

• Health professional
• Research
• Academia

Expertise/experience

• Interventional radiology
• Cardiology
• Cardiovascular surgery
• Interventional cardiology
• Clinical perfusion
• Biomedical engineering
• Cardiac electrophysiology
• Neurovascular surgery
  

1. Direct financial interests

1. Current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares or bonds, with the regulated industry

2. Indirect financial interests

1. Within the past five years, payment from regulated industry for work done or being done, including past employment, contracts or consulting; or financial support including research support, personal education grants, contributions, fellowships, sponsorships, and honoraria^{Footnote 1}.
2. Within the past five years, materials, discounted products, gifts, or other benefits, or attendance at meetings where all or part of the travel and accommodation costs were provided by the regulated industry^{Footnote 2}.
3. Within the last three years, grants or other funding from the regulated industry to any of the organizations where you are currently employed or participate in internal decision making^{Footnote 3}.

3. Intellectual interests

1. Within the last five years, any formal advice or opinion to industry, a government organization or a non-government organization on a matter of relevance to the SAC-MDUCS.
2. Within the last five years, any published or publicly stated point of view on issues of relevance to the SAC-MDUCS mandate.
3. Current professional or volunteer affiliations such as membership of professional societies, lobbying, public interest or advocacy groups, of relevance to the SAC-MDUCS.

4. Other

1. Any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable grounds for concern regarding the integrity and objectivity of your participation.

Biographies and Affiliations and Interests Summaries

Name and Indicated Sector/Perspective and Expertise - with Responses

Name and Indicated Sector/Perspective and Expertise Experience		Summary of Responses
Core Members
John Ducas, MD, FRCPC (Chair)	Health Professional/Academia; Cardiology	1a) No	2a) No	2b) Yes	2c) No	3a) No	3b) No	3c) No	4a) Yes
		Comments: Financially supported jointly by a number of device manufacturers to attend an annual meeting at Mont Tremblant yearly. Receives honoraria for lecturing for the Pharmaceutical Industry. Also funded by a number of pharmaceutical companies for contract clinical research not related to device industry.
Luc Bilodeau, MD, FRCPC	Health Professional/Academia; Interventional Cardiology	1a) No	2a) Yes	2b) Yes	2c) No	3a) Yes	3b) No	3c) No	4a) No
		Comments: Principal investigator for numerous medical research centres, medical technology companies and pharmaceutical companies. Has published in numerous scientific journals. Member of the Strategic Advisory Board and Primary Investigator for two separate medical technology companies.
Christopher Feindel, MD, FRCSC, FACS, MSc	Academia/Research; Cardiac Surgery	1a) Yes	2a) Yes	2b) No	2c) No	3a) No	3b) No	3c) Yes	4a) No
		Comments: Safety Committee for a Medical Device Company. Board member of the Cardiac Care Network of Ontario (CCN), Chair of the Cardiovascular Surgery Working Group of CCN, member of the Canadian Cardiovascular Society, Society of Thoracic Surgeons and American Association for Thoracic Surgeons.
Marino Labinaz, MD, FRCPC, FACC	Academia; Interventional Cardiology	1a) No	2a) Yes	2b) Yes	2c) No	3a) Yes	3b) No	3c) Yes	4a) No
		Comments: Has received speaking honoraria (multiple talks); conducted clinical trials as site principal investigator for various pharmaceutical companies and has received unrestricted grants for educational symposium. Receives travel reimbursement from medical technology companies. Advisory Board member for a pharmaceutical company and a medical technology company and is also a member of: Canadian Association of Interventional Cardiologists, Canadian Cardiovascular Society and American College of Cardiology.
Alan Menkis, MD, FRCSC	Health Professional/Academia; Cardiovascular and Thoracic Surgery	1a) No	2a) No	2b) No	2c) Yes	3a) Yes	3b) Yes	3c) Yes	4a) No
		Comments: Has received unrestricted grants for research and educational programs from medical technology companies. As Cardiac Science Director, provides advice and opinion to principal investigators through the Winnipeg Regional Health Authority. Has published in numerous scientific journals.
Joaquim Miró, MD, FRCPC	Health Professional/Academia; Paediatric-Cardiologist	1a) Yes	2a) No	2b) No	2c) No	3a) Yes	3b) No	3c) No	4a) No
		Comments: Occasional proctor for a medical company and a past member of advisory committee on atrioventricular (AV) block for a medical corporation.
L. Brent Mitchell, MD, FRCPC, FACC	Health Professional/Academia; Cardiac Electrophysiology	1a) No	2a) Yes	2b) Yes	2c) No	3a) Yes	3b) Yes	3c) Yes	4a) No
		Comments: Has received funding from a medical technology company as member of events committee past 5 years ongoing. Received honoraria from biomedical companies for speaking / teaching at numerous conferences for the past 5 years, and ongoing. Travel costs have been reimbursed by most companies but only when providing speaking / teaching service. Volunteers at the Alberta Health Services on the implantable cardiac device tender. Member of the Canadian Heart Rhythm Society, Heart and Stroke Foundation of Alberta, Northwest Territories, Nunavut, Heart Rhythm Society and American Heart Association.
Tofy Mussivand, PhD, FRSC	Academia; Biomedical Engeneering	1a) No	2a) No	2b) No	2c) No	3a) Yes	3b) No	3c) Yes	4a) No
		Comments: Expert reviewer for a medical technology company and has provided expert opinion to the court on medical devices and independent review of the scientific basis of other expert's testimony. Directly compensated as a consultant. Has represented Canada on International Organisation for Standardization (ISO), and is the Chairman of Canadian Committee on Surgical Implants for Canadian Standards Association and Chair of ISO Mechanical Circulatory Devices.
Ratika Parkash, MD, MSc, FRCPC	Health Professional/Academia; Cardiology/Electrophysiology	1a) No	2a) Yes	2b) Yes	2c) Yes	3a) Yes	3b) No	3c) Yes	4a) No
		Comments: None
Nancy Poirier, MD	Health Professional; Paediatric and Adult Congenital Cardiac Surgery	1a) No	2a) No	2b) No	2c) No	3a) No	3b) No	3c) No	4a) No
		Comments: None
Barry Rubin, MD, PhD, FRCSC	Health Professional/Research; Vascular Surgery	1a) No	2a) No	2b) No	2c) Yes	3a) Yes	3b) No	3c) Yes	4a) No
		Comments: Toronto General Hospital receives an educational grant to support a vascular surgery fellow. Member of the Canadian Institutes of Health Research (CIHR) Expert Panel on Multiple Sclerosis and co-Chair of the Ontario Multiple Sclerosis Expert Panel. Medical Director of the Peter Munk Cardiac Center.
John G. Webb, MD	Health Professional/Academia; Cardiology	1a) Yes	2a) Yes	2b) No	2c) No	3a) Yes	3b) Yes	3c) Yes	4a) No
		Comments: Consultant for numerous medical technology companies. Principal investigator, consulting and physician training for a company leading in cardiovascular technologies. Attends meetings with the United States Food and Drug Administration (FDA) and with the Australian equivalent on the subject of transcatheter valves. Has giving numerous international presentations and has many published articles in numerous scientific journals. Member of the Society of Cardiac Angiography and Interventions (Orphan device committee) American College of Cardiology (Interventional Council) Canadian Association of Interventional Cardiologists.
Raymond Yee, MD, FRCPC	Academia; Cardiology
		1a) No	2a) Yes	2b) No	2c) No	3a) No	3b) No	3c) Yes	4a) No
		Comments: Consultant / advisor for a medical technology company. Receives honoraria fees twice a year and has received a research grant from a medical technology company. Also a member of the Canadian Hearth Rhythm Society and Canadian Cardiovascular Society.
Ad hoc members
Charles R. Kerr, MD, FRCPC	Health professional/Academia; Cardiology	1a) No	2a) Yes	2b) No	2c) No	3a) No	3b) No	3c) No	4a) No
		Comments: Has received research grants from a medical technology company.
Bob Kiaii, BSc, MD, FRCSC	Health professional/Academia; Cardiovascular surgery	1a) No	2a) Yes	2b) Yes	2c) Yes	3a) Yes	3b) Yes	3c) No	4a) No
		Comments: Received a research grant from a medical technology company in 2004 and 2006. Receives honoraria for consulting, providing proctorship and speaking, 2005-2009 from various institutions and companies. All travel and accommodation cost provided by a medial technology company. Has been granted an industry funded grant from a medical technology company for "Prophylactic Pulmonary Vein Isolation as Adjunct to Coronary Artery Bypass Grafting". Past Member of Advisory Board for a medical technology company for the project "Liberty Left Atrial Appendage Occlusion Device" and has given an oral presentation at the American Association of Thoracic Surgeons (AATS).
Stephen Lownie, MD, FRCSC	Health professional/Academia; Neurovascular surgery/Neurointerventionalist	1a) Yes	2a) No	2b) Yes	2c) No	3a) No	3b) No	3c) No	4a) No
		Comments: Receives shares of stock as support for a research project. Has received a one-time travel expense support to serve as a member of an international advisory committee of neurosurgeons, providing recommendations concerning angiography equipment.
John Lewis Sapp Jr., BSc, BSc (Med), MD, FRCPC	Health professional/Academia; Cardiac Electrophysiology	1a) No	2a) Yes	2b) Yes	2c) Yes	3a) Yes	3b) No	3c) Yes	4a) No
		Comments: Has received multiple speakers' honoraria and research funding from numerous medical technology companies. Travel has been reimbursed for research and clinical presentations. Director of Electrophysiology for Capital District Health authority which has received research funding from numerous medical technology companies. Paid consultant for advisory board attendance. He is a member of the Heart Rhythm Society, Canadian Cardiovascular Society, and an executive member of the Canadian Hearth Rhythm Society.
Christopher Simpson, MD, FRCPC, FACC	Health professional/Academia; Cardiology	1a) No	2a) No	2b) No	2c) Yes	3a) No	3b) Yes	3c) No	4a) No
		Comments: Various medical technology companies have provided funding (for example, research nurse salaries and Fellow's salaries) as part of hospital contracts. As President of Canadian Heart Rhythm Society, he has provided numerous quotes on recalled products in the medical and lay press.